Xixi Zhao Editor

Adam E. M. Eltorai, MD, PhD completed his graduate studies in Biomedical Engineering and Biotechnology along with his medical degree from Brown University. His work has spanned the translational spectrum with a focus on medical technology innovation and development. Dr. Eltorai has published numerous articles and books. Nancy Patterson is a Venture Analyst and the President and CEO and Founder of Strategy Inc. (in 2000), a lifescience market analysis and valuation company for US and International clients. She has over 18 years’ experience in senior business development and marketing roles with emerging technology medical device companies. Patterson is an immunologist from University of Michigan and also has an MBA from University of Southern California. Sushrut S. Waikar, MD, MPH is a clinician-scientist and nephrologist at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, where he is Chief of Nephrology and the Norman G. Levinsky Professor of Medicine. Dr. Waikar’s research interests and active projects include biomarker discovery/validation, complications of renal replacement therapy, kidney functional reserve, kidney functional MRI, and clinical trials in CKD. Xixi Zhao, MD is an adult and pediatric nephrologist. She is a recent graduate of the Stanford Adult and Pediatric Nephrology Fellowship and Stanford Biodesign Innovation Fellowship. Dr. Zhao has a passionate vision for transforming medicine through technology and innovation. She is the lead author of several publications and a frequent speaker at conferences.